Prescription drug · ANDA
Aprepitant NDC 68462-585
Aprepitant 125 mg/1 · Capsule · Oral · Glenmark Pharmaceuticals Inc., USA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68462-585-76 | 68462058576 | 1 BLISTER PACK in 1 CARTON (68462-585-76) / 6 CAPSULE in 1 BLISTER PACK (68462-585-40)Marketed from Oct 12, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aprepitant
- Generic name (nonproprietary)
- aprepitant
- Active ingredients
- Aprepitant — 125 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207777
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Neurokinin 1 Antagonists (Mechanism)
- Identifiers
- Product ID 68462-585_41f97256-ac39-413d-8b2f-5fb7ad429143SPL ID 41f97256-ac39-413d-8b2f-5fb7ad429143SPL set ID d72e0e10-4557-41b0-b65d-d395468cad19RxCUI 403810, 403811, 644088, 754508UNII 1NF15YR6UYUPC 0368462585764, 0368462112335, 0368462584767, 0368462583401
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468462058576followed by a unit qualifier and the quantityPackage 68462-0585-76. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 207777
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | Glenmark Pharmaceuticals Inc., USA | 68462-584 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | Glenmark Pharmaceuticals Inc., USA | 68462-583 |
| Aprepitant | — | Kit | Glenmark Pharmaceuticals Inc., USA | 68462-112 |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-666 |
| Aprepitant | — | Kit | BluePoint Laboratories | 68001-669 |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-667 |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | BluePoint Laboratories | 68001-668 |